Search - tctmd.com

Displaying 901 - 920 of 1033

Sort: Relevancy | Date

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Presentation SOLACI 2013

The Importance of DAPT for the Stent

Presenter: Expedito E. Ribeiro

July 24, 2013

Presentation SOLACI 2013

DAPT for ACS: Focus on Patient Secondary Prevention

Presenter: Roberto Botelho

July 24, 2013

News Daily News

轻微卒中/短暂性脑缺血发作后，双联抗血小板疗法与阿司匹林相比能够减少卒中复发

July 24, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

News Daily News

Una Revisión de JAMA Aborda las Complejidades del Tratamiento Médico tras una PCI

Caitlin E. Cox

July 11, 2013

News Daily News

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Caitlin E. Cox

July 11, 2013

News Daily News

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Caitlin E. Cox

June 20, 2013

News Daily News

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Caitlin E. Cox

June 20, 2013

Presentation TVT 2013

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Presenter: Ted Feldman

June 15, 2013

News Opinion Conversations in Cardiology

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

June 03, 2013

News Industry News

OrbusNeich Launches World’s First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

May 27, 2013

Presentation EuroPCR 2013

The Unplanned DAPT Discontinuation Patient: How Can I Make Informed Decisions?

Presenter: Sigmund Silber

May 22, 2013

News Industry News

CID releasesDemonstr8 randomised trialresults during Late Breaking Trials

May 22, 2013

News Industry News

CID SpA Sponsors a Major Symposium at EuroPCR 2013 on Thursday 23rd of May

May 17, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

L.A. McKeown

May 03, 2013

Presentation

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Presenter: K. Tandjung

April 26, 2013

Advertisement

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

The Importance of DAPT for the Stent

DAPT for ACS: Focus on Patient Secondary Prevention

轻微卒中/短暂性脑缺血发作后，双联抗血小板疗法与阿司匹林相比能够减少卒中复发

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Una Revisión de JAMA Aborda las Complejidades del Tratamiento Médico tras una PCI

JAMA Review Tackles Intricacies of Medical Therapy After PCI

Un Registro Danés Sugiere que la Aspirina No es Necesaria en Pacientes con FA tras un IM o PCI

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Is Triple Therapy a Triple Threat for Patients? DAPT and Chronic Anticoagulation

Conversations in Cardiology: Bridging Antithrombotic Therapy Between PCI & CABG

OrbusNeich Launches World’s First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

The Unplanned DAPT Discontinuation Patient: How Can I Make Informed Decisions?

CID releasesDemonstr8 randomised trialresults during Late Breaking Trials

CID SpA Sponsors a Major Symposium at EuroPCR 2013 on Thursday 23rd of May

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

Clinical Outcome Following Discontinuation of DAPT After 12 months in Real-World Patients Treated with Second-Generation ZES and EES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content